Supplementary Fig. S13 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity

Haifeng Pan; Siyuan Yu; Haoyun Zhuang; Han Yang; Jinlu Jiang; Haihui Yang; Shuling Ren; Guoxing Luo; Xuan Yu; Shuping Chen; Yanhua Lin; Roufang Sheng; Shiyin Zhang; Quan Yuan; Chenghao Huang; Tianying Zhang; Tingdong Li; Shengxiang Ge; Jun Zhang; Ningshao Xia

doi:10.1158/2326-6066.26145159

Abstract

Supplementary Fig. S13. The modified eTAT delivery system demonstrated comparable efficiency in interacting with CpG molecules and in the co-delivery of antigen and CpG in vivo.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pan et al. (2024) studied this question.

synapsesocial.com/papers/68e61b6eb6db6435875adb40 https://doi.org/10.1158/2326-6066.26145159

View Full Paper

Ask AI

Bookmark

Share

Supplementary Fig. S13 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity

Abstract

Discussion

Cite This Study

Supplementary Fig. S13 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity

Abstract

Discussion

Cite This Study

Keep reading

Keep reading